| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |